4 tridentatus, T. gigas, and Carcinoscorpius (C.) rotundicauda-each having a distinct geographic distribution. L. polyphemus is distributed along the east coast of North America, and the other three species are distributed throughout Southeast Asia. In Japan, T. tridentatus inhabits coastal areas of the northern part of Kyushu as well as the Inland Sea (Fig. 2) . T.
tridentatus is relatively long-lived; the embryo molts four times within the fertilized eggs, and after hatching it molts every year for 15 years to become a mature adult (15) . When Iwanaga arrived at Kyushu University, he understood his good fortune to have a position at one of the best places to investigate the host defense system of the horseshoe crab.
HISTRICAL BACKGROUND OF HORSESHOE CRAB STUDIES
Hemolymph coagulation of L. polyphemus was described, perhaps for the first time, by William H. Howell of Johns Hopkins University in 1885 (16) . Howell aptly concluded that there was a striking resemblance in the methods by which corpuscles unite to form clots in the blood of mammals and in L. polyphemus, suggesting that the formation of fibrous gels in the two cases may result from an essential similar series of changes. Early studies on hemolymph gelation and granular hemocytes were performed by Leo Loeb, and granular hemocytes were named as amebocytes by virtue of their amoeboid movement. Interestingly, Hideyo Noguchi at the University of Pennsylvania-who later gained fame from his studies on snake venoms and syphilology-in 1903 injected horse red blood cells into L. polyphemus and reported a 5 strong hemagglutinating activity in hemolymph plasma (17) . In 1956, Frederik Bang of Johns Hopkins University and the Marine Biological Laboratory in Woods Hole, published a landmark study on horseshoe crab hemolymph coagulation, finding that L. polyphemus intravascular clotting was induced by an injection of a ubiquitous marine pathogen, Vibrio (18) . In 1964, Jack Levin and Bang made the important discovery that coagulation occurs when exposed to bacterial endotoxin (LPS). Moreover, in 1968, they found that procoagulant activity and a clottable protein are located in granular hemocytes and not in hemolymph plasma. They immediately recognized the high sensitivity of LPS-mediated hemolymph coagulation and its applicability to hemocyte lysate, named Limulus amebocyte lysate (LAL), for assaying the bacterial endotoxin. These historical events have been described in detail in reference 16. The clottable protein was named coagulogen by virtue of its functional similarity to mammalian fibrinogen.
MOLECULAR MECHANISM OF HEMOLYMPH COAGULATION
In the early 1970s, Makoto Niwa of Osaka City University Medical School displayed a micrograph for hemolymph clots to Iwanaga at Osaka University's Institute for Protein
Research. Iwanaga was very impressed to find a fibrin-like structure of clots on the micrograph. He then started to purify coagulogen and to biochemically characterize the proteolytic conversion of coagulogen to coagulin, using a partially purified protease, the 6 clotting enzyme. Shin Nakamura (now at Kyoto University) and Iwanaga for its activity, and contains no γ-carboxyglutamic acid in the sequence (19, 20) .
After the LAL test for detecting LPS was established, Iwanaga developed a chromogenic peptide substrate for the clotting enzyme (4) . He showed that the proclotting enzyme is not an LPS-sensitive protease zymogen and that another protease zymogen that is partially purified, named factor B-since the zymogen was present in "fraction B" separated by heparin-agarose chromatography of hemocyte lysate-is involved in the proteolytic activation of the proclotting enzyme to the clotting enzyme. Upon further purification of fraction B by introducing dextran-sulfate column chromatography, an LPS-sensitive serine protease zymogen factor C was identified in "fraction C" and characterized in detail (21) (22) (23) . Takanori   7 Nakamura (now at Kagawa University), Takashi Morita (who recently retired from Meiji Pharmaceutical University), and Iwanaga highly purified three serine protease zymogens-the proclotting enzyme, factor B, and factor C-and succeeded in reconstituting LPS-mediated hemolymph coagulation with the purified protease zymogens and coagulogen, thus establishing the cascade-type reaction (19, 21) . Chromogenic substrates highly specific to each protease in the cascade were developed for the purification and characterization of the enzymes. They contributed the development of the second-generation LAL test, which is much more sensitive and quantitative than the original test, which is based on the turbidity of the lysate (4). separated by heparin-agarose chromatography of hemocyte lysate-and reported that granular hemocytes contain two independent coagulation pathways, LPS-mediated and BDG-mediated pathways, which respond to Gram-negative bacteria and fungi, respectively (25) . However, another 10 years passed before factor G was obtained with high homogeneity, due to its instability during purification. Muta and Iwanaga reported that purified factor G is a 8 heterodimeric serine protease zymogen with a large BDG recognition subunit and a small protease zymogen subunit (26, 27) . The purified factor G was sensitive to as low as 1 ng/ml BDG.
As a result, the protease zymogens of the hemolymph coagulation were identified. This resulted in the first discovery of a proteolytic cascade induced by the pathogen-associated molecular patterns (PAMPs), LPS and BDG, in invertebrates as an important milestone for studies on invertebrate immunity. In summary, factor C secreted from granular hemocytes is autocatalytically activated in the presence of Gram-negative bacteria or LPS, and activated factor C activates coagulation factor B, which in turn converts the proclotting enzyme into the clotting enzyme. The clotting enzyme then promotes the proteolytic conversion of coagulogen to coagulin, releasing the activation peptide, and the resulting coagulin spontaneously forms an insoluble polymer. Alternatively, activated factor G in the presence of BDG triggers the activation of the proclotting enzyme to the clotting enzyme. In this manner, factor C and factor G independently serve to couple the recognition of LPS and BDG, respectively and thus to form a physical barrier at the site of microbial invasion (Fig. 3) .
Coagulogens derived from the four species were completely sequenced at protein level by Toshiyuki Miyata (now at the National Cardiovascular Center) and Iwanaga. The sequencing indicated that T. tridentatus and C. rotundicauda are phylogenetically more closely related than the other species, and that L. polyphemus is evolutionarily distant from 9 the other three species (5). In the early 1980s, Miyata and Iwanaga introduced cutting-edge technologies for molecular cloning and immediately completed the nucleotide sequence of coagulogen from T. tridentatus (28) . Muta and Iwanaga cloned cDNAs for all the protease zymogens involved in the coagulation cascade to reveal their molecular architectures (20, (29) (30) (31) . The proclotting enzyme and factor B harbor a unique common motif, named the clip-like domain, at their NH 2 -terminal region (20, 29) . Later, other groups identified homologous clip-like domains in the NH 2 -terminal regions of many insect serine protease zymogens (10, 11) . Factor C was a unique mosaic protein that contained a Cys-rich region, an epidermal growth factor-like domain, five Sushi domains (also designated as complement control protein modules or short consensus repeats), and a C-type lectin domain, in addition to a typical serine protease domain at the COOH-terminus (30) . This was the first report that a Sushi domain found in mammalian complement-related proteins is involved in the invertebrate serine protease family. Factor G was a heterodimeric serine protease zymogen composed of two noncovalently associated subunits,  and . The  subunit contains a serine protease domain, and the  subunit comprises three types of noncatalytic glycosidase-like modules: a single β-1,3-D-glucanase A1-like module, three tandem xylanase A-like modules, and two tandem xylanase Z-like modules (31) .
During the purification of coagulation factors, the presence of their inhibitors in the hemocytes was suggested. Kawabata and Iwanaga then showed that the proteolytic cascade 10 of hemolymph coagulation is regulated and scavenged by three types of serine protease inhibitors (serpins 1-3) with relatively high specificities for activated factor C, the clotting enzyme, and the activated factor G, respectively (32) (33) (34) . Interestingly, horseshoe crab serpins were more closely related to mammalian serpins than to insect serpins: for example, horseshoe crab serpin-1 versus human plasminogen activator inhibitor (40% sequence identity) and silkworm antichymotrypsin (27%) (32) . Mammalian serpin-protease complexes are hypothesized to be rapidly cleared through a cell-surface receptor, which recognizes a hydrophobic consensus sequence that is selectively exposed on the complexed forms of serpins. This consensus sequence was conserved in horseshoe crab serpins in the corresponding region. Horseshoe crab serpins appear to prevent diffusion of the activated forms of coagulation factors by scavenging activated proteases that escape into the hemolymph from the surfaces of microbes at the site of injury, and thereby prevent unnecessary clot formation (Fig. 3) .
EVOLUTIONARY MEANING OF THE COAGULATION CASCADE OF THE HORSESHOE CRAB
At a site of vascular injury, the mammalian coagulation system acts locally on the cell membrane phospholipid surface in cooperation with Ca
2+
. In an analogous fashion, the hemolymph coagulation in the horseshoe crab is restricted to the surfaces of invading 11 pathogens, such as Gram-negative bacteria and fungi. This mechanistic similarity between the coagu1ation cascades of vertebrates and those of horseshoe crabs may lead to the erroneous assumption of a common evolutionary origin. The three-dimensional structure of coagulogen was determined in collaboration with Robert Huber and Wolfram Bode of the Max Plank Institute, and indicated no structural similarity or evolutionary relatedness of coagulogen to fibrinogen (35) . The crystal structure of coagulogen exhibited a striking topological similarity to the neurotrophin nerve growth factor, providing the first evidence for a neurotrophin fold in invertebrates.
A protease cascade in Drosophila is well characterized as the morphogenetic cascade for determining embryonic dorsal-ventral polarity, leading to the production of a Toll 1igand spätzle. The spätzle is postulated to belong to the nerve growth factor family and possesses a cystine knot motif similar to that of coagulogen (35, 36) . In addition, a clip-like domain located in the NH 2 -terminal region of horseshoe crab coagulation factor B and the proclotting enzyme was identified in the proteins snake and easter of the Drosophila Toll pathway (10, 11, 36) . The structural similarity between coagulogen and spätzle, as well as that between the clip-like domain containing serine protease zymogens participating in the two cascades, together suggest that the two functionally distinct cascades may have a common evolutionary origin. Now we know that the Drosophila Toll pathway also controls resistance to fungal and Several tachyplesin homologues, named polyphemusins, were also isolated from L.
polyphemus by the acid-extraction method (42) . Thereafter, the acid extraction of basic peptides from hemocyte debris became a standard methodology for purifying horseshoe crab 13 antimicrobial peptides. Iwanaga then reported the synthesis of tachyplesin as a precursor protein with an acidic extension peptide and that tachyplesin is localized in the dense granules rather than in the large granules in the hemocytes (43) .
In 1985, Copeland and Levin examined the morphology and fine structure of the granular hemocyte of L. polyphemus, and found that the hemocyte contains two types of granules; large ones and dense ones. Yoshihiro Toh (who recently retired from Kyushu University) and Iwanaga, using immunocytochemical analysis, revealed an interesting characteristic of the hemocyte granules of T. tridentatus: the large granules contain coagulogen, proclotting enzyme, and factor C, whereas the dense granules contain only tachyplesin (20, 30, 44) . In 2004, an LPS sensor on the hemocyte surface was finally identified; factor C also existed on the hemocyte surface as a biosensor for LPS (63) . Upon activation by LPS, factor C initiated hemocyte exocytosis via a G-protein-dependent exocytic pathway that was dependent on the proteolytic activity of factor C (Fig. 3) . Factor C interacted with LPS via its NH 2 -terminal Cys-rich domain. The binding parameter, however, could not explain the extraordinarily high sensitivity of the hemolymph for LPS as low as ~10 -13 g/ml (~10 -14 M).
In 2005, an enhancing mechanism of LPS sensitivity of the hemolymph was solved. 17 Interestingly, tachyplesin in the exocytosed fluid acted as a secondary secretagogue, thereby dramatically enhancing the sensitivity of the hemocyte to LPS.
Through steady and persistent studies on the horseshoe crab host defense system, Iwanaga has made great strides in the field, catapulting horseshoe crabs into the limelight not as a living fossil but as a comprehensively characterized precedent model for invertebrate innate immunity. Now we know that LPS-induced hemocyte exocytosis in the horseshoe crab leads not only to coagulation but also activates a sophisticated innate immune response network that coordinately induces pathogen recognition, prophenoloxidase activation, and TGase-dependent wound healing. Fig. 1 . Sadaaki Iwanaga. 
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